UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Neurourology and urodynamics, 2014-01, Vol.33 (1), p.17-30

2014

Volltextzugriff (PDF)

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

BJU international, 2017-10, Vol.120 (4), p.562-575

2017

Volltextzugriff (PDF)

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

BJU international, 2015-06, Vol.115 (6), p.968-977

2015

Volltextzugriff (PDF)

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

European urology focus, 2019-03, Vol.5 (2), p.280-289

2019

Volltextzugriff (PDF)

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

BJU international, 2017-11, Vol.120 (5), p.611-622

2017

Volltextzugriff (PDF)

A proof-of-concept study: Mirabegron, a new therapy for overactive bladder

Neurourology and urodynamics, 2013-11, Vol.32 (8), p.1116-1122

2013

Volltextzugriff (PDF)

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Neurourology and urodynamics, 2012-01, Vol.31 (1), p.13-21

2012

Volltextzugriff (PDF)

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S6-S13

Chapple, Christopher

2014

Volltextzugriff (PDF)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

International journal of clinical practice (Esher), 2017-05, Vol.71 (5), p.e12944-n/a

2017

Volltextzugriff (PDF)

It is a great pleasure to introduce to you the fourth edition of this year

Neurourology and urodynamics, 2015-04, Vol.34 (4), p.299-299

Chapple, Christopher

2015

Volltextzugriff (PDF)

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

Expert opinion on pharmacotherapy, 2006-12, Vol.7 (17), p.2421-2434

Chapple, Christopher R

2006

Volltextzugriff (PDF)

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S1-S1

Chapple, Christopher

2014

Volltextzugriff (PDF)

A mixed methods study to assess the feasibility of a randomised controlled trial of invasive urodynamic testing versus clinical assessment and non-invasive tests prior to surgery for stress urinary incontinence in women: the INVESTIGATE-I study

Trials, 2015-09, Vol.16 (1), p.400-400, Article 400

2015

Volltextzugriff (PDF)

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions

International journal of clinical practice (Esher), 2021-04, Vol.75 (4), p.e13870-n/a

2021

Volltextzugriff (PDF)

Lower urinary tract symptoms in men

BMJ, 2007-01, Vol.334 (7583), p.2-2

2007

Volltextzugriff (PDF)

OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity

Neurourology and urodynamics, 2013-11, Vol.32 (8), p.1109-1115

2013

Volltextzugriff (PDF)

The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review

Italian journal of urology and nephrology, 2019-12, Vol.71 (6), p.569

2019

Volltextzugriff (PDF)

Biomaterials for Pelvic Floor Reconstructive Surgery: How Can We Do Better?

BioMed research international, 2015-01, Vol.2015 (2015), p.1-20

2015

Volltextzugriff (PDF)

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study

European urology focus, 2024-01, Vol.10 (1), p.90-97

2024

Volltextzugriff (PDF)

Bladder function after radical hysterectomy for cervical cancer

Neurourology and urodynamics, 2015-04, Vol.34 (4), p.309-315

2015

Volltextzugriff (PDF)

Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

Neurourology and urodynamics, 2019-02, Vol.38 (2), p.779-792

2019

Volltextzugriff (PDF)

Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long‐term extension study

Neurourology and urodynamics, 2017-02, Vol.36 (2), p.368-375

2017

Volltextzugriff (PDF)

Assessment of Electrospun and Ultra-lightweight Polypropylene Meshes in the Sheep Model for Vaginal Surgery

European urology focus, 2020-01, Vol.6 (1), p.190-198

2020

Volltextzugriff (PDF)

The development of the ICIQ‐UAB: A patient reported outcome measure for underactive bladder

Neurourology and urodynamics, 2019-03, Vol.38 (3), p.996-1004

2019

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaNephrology. Urinary Tract Diseases

SpracheEnglisch

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Erscheinungsjahr

n.n

Thema

Humans
(23)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Urology & Nephrology
(17)
Female
(16)
Adult
(10)
Male
(10)
Urinary Bladder, Overactive - Drug Therapy
(10)
Middle Aged
(9)
Urinary Incontinence
(9)
Aged
(7)
Quality Of Life
(7)
Overactive Bladder
(6)
Patients
(6)
Acetanilides - Therapeutic Use
(5)
Clinical Trials
(5)
Thiazoles - Therapeutic Use
(5)
Urinary Bladder
(5)
Urinary Bladder, Overactive - Physiopathology
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

A proof-of-concept study: Mirabegron, a new therapy for overactive bladder

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

It is a great pleasure to introduce to you the fourth edition of this year

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

A mixed methods study to assess the feasibility of a randomised controlled trial of invasive urodynamic testing versus clinical assessment and non-invasive tests prior to surgery for stress urinary incontinence in women: the INVESTIGATE-I study

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions

Lower urinary tract symptoms in men

OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity

The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review

Biomaterials for Pelvic Floor Reconstructive Surgery: How Can We Do Better?

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study

Bladder function after radical hysterectomy for cervical cancer

Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long‐term extension study

Assessment of Electrospun and Ultra-lightweight Polypropylene Meshes in the Sheep Model for Vaginal Surgery

The development of the ICIQ‐UAB: A patient reported outcome measure for underactive bladder

Aktive Filter

Suchergebnisse filtern